Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
Dominique L. Braun(University of Zurich), Robert Gottlieb(Baylor University Medical Center), Eleftherios Mylonakis(Houston Methodist), Karla Zepeda(Cedars-Sinai Medical Center), Vidya Menon(Lincoln Medical Center), Sanjay Bhagani, Barnaby Edward Young(National Centre for Infectious Diseases), Nicole Engen(Fairview Health Services), Philip A. Robinson(Hoag Memorial Hospital Presbyterian), Lianne Siegel(University of Minnesota), Andrew M. Vekstein, Barbara W. Trautner(Washington University in St. Louis), Ivan Kimuli(Makerere University), Nnakelu Eriobu(Michael E. DeBakey VA Medical Center), David Chien Lye(Agency for Science, Technology and Research), Vasiliki Rapti(National and Kapodistrian University of Athens), Amiran Baduashvili(University of Colorado Hospital), David M. Vock(Clinical Research Institute), Uriel Sandkovsky, Alyssa Hughes(University of California, San Francisco), Zafeiria Barmparessou(National and Kapodistrian University of Athens), Mamta K. Jain(The University of Texas Southwestern Medical Center), Michael R. Waters(Washington University in St. Louis), Kirk U. Knowlton(Intermountain Medical Center), Fadi Shehadeh, Peter Chen(Cedars-Sinai Medical Center), Alison Rodger(Royal Free London NHS Foundation Trust), Alice Osuji(Parkland Health & Hospital System), Diong Shiau Hui(Tan Tock Seng Hospital), Konstantinos N. Syrigos(National and Kapodistrian University of Athens), J. Scott Overcash(Precision Research Institute), Ioannis Kalomenidis(Evangelismos Hospital), Nilima Mosaly(Duke University Hospital), Greg Grandits
Cited by 31
Related Papers
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k